Miquel Salvà

Miquel Salvà is an experienced executive in the pharmaceutical industry, currently serving as Executive Director of DMPK and Safety at Syngene International Limited since July 2022. Prior to this role, Miquel worked as an Independent Consultant specializing in Clinical & Preclinical DMPK and Non-clinical Safety from February 2022 to July 2022, providing expert advice on various aspects of drug development and safety assessment. Miquel's extensive career at Almirall spanned over 30 years, including positions such as Director of Preclinical Development, Deputy Director of Biological Development, and Head of Pharmacokinetics and Drug Metabolism. Educational qualifications include dual Executive MBAs from Georgetown University and Esade, alongside a PhD in Biochemistry and a Bachelor of Science in Chemistry from Universitat Autònoma de Barcelona.